Zhongheng Group: Holding Subsidiary Hunan Kangyuan Receives Approval Letter for Drug Supplementary Application

Zhongheng Group announced that its holding subsidiary, Hunan Kangyuan Pharmaceutical Co., Ltd., has received the "Drug Supplementary Application Approval Notice" for the sodium lactate Ringer's solution issued by the State Food and Drug Administration. The drug has passed the evaluation of generic drug quality and efficacy consistency, and the approval allows for changes to the drug prescription, production process, quality standards, packaging materials, containers, and revision of the drug instructions. The validity period is 18 months. The address of Hunan Kangyuan Pharmaceutical Co., Ltd. is No. 8 Kangping Road, Liuyang Economic and Technological Development Zone, Hunan Province. The original drug approval number is valid until July 16, 2028.